HCPCS Level IIdrugActive
J8670
Rolapitant, oral, 1mg
BETOS: O1E
Effective: 2017-01-01
Referenced in 2 policies
Description
Rolapitant, oral, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Varubi Oral
Manufacturer
TerSera Therapeutics LLC
HCPCS Dosage
1 MG
Billing Units
180.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.